COMMUNIQUÉS West-GlobeNewswire

VitalHub Introduces Harm Reduction Software

14/05/2018 - 13:30

TORONTO, May 14, 2018 (GLOBE NEWSWIRE) -- VitalHub Corp. (the “Company” or “VitalHub”) (TSXV:VHI) is pleased to announce the introduction of a harm reduction module, aimed at the growing opioid epidemic facing North [...]

New Scientific Advisors Focused on Cell Therapy in Immuno-Oncology and Autoimmunity Join Intellia Therapeutics

14/05/2018 - 13:30

CAMBRIDGE, Mass., May 14, 2018 (GLOBE NEWSWIRE) -- Intellia Therapeutics, Inc. (NASDAQ: NTLA ), a leading genome editing company focused on developing curative therapeutics using CRISPR/Cas9 technology, announced new [...]

Marinus Pharmaceuticals to Present at the UBS Global Healthcare Conference

14/05/2018 - 13:30

RADNOR, Pa., May 14, 2018 (GLOBE NEWSWIRE) -- Marinus Pharmaceuticals, Inc. (Nasdaq: MRNS ), a biopharmaceutical company dedicated to the development of innovative therapeutics to treat epilepsy and neuropsychiatric [...]

Transactions under Novozymes’ stock buyback program

14/05/2018 - 13:21

Please read the full announcement in the attached PDF Attachment 2018_31_Stock_Buybackprogram_EN

Trading by management and close relations of management

14/05/2018 - 13:14

Read the full announcement in the attached file Attachment 2018_30_Trading_by_management_EN

Share buy-back week 19/2018

14/05/2018 - 13:04

Announcement 14 May 2018 Coloplast – transactions in connection with share buy-back programme As mentioned in Announcement No. 3/2018 Coloplast has initiated the first part of the share buy-back programme totalling up [...]

ChromaDex Appoints Nobel Laureate, Professor Sir John Walker, to the Scientific Advisory Board

14/05/2018 - 12:30

World-Renowned British Chemist to Assist in Uncovering New Applications for Nicotinamide Riboside and Mitochondrial Health IRVINE, Calif., May 14, 2018 (GLOBE NEWSWIRE) -- ChromaDex Corp. (NASDAQ: CDXC ), an integrated [...]

Evoke Pharma Reports First Quarter 2018 Results and Highlights

14/05/2018 - 12:30

The Company will hold a conference call following submission of Gimoti NDA NDA submission for Gimoti™ on track for second quarter of 2018 Announced discovery of sex-based pharmacokinetic differences for Gimoti Waiver of [...]

Immunicum AB (publ) Announces Upcoming Presentations and Attendances at Conferences in May and June

14/05/2018 - 12:01

Press Release 14 May 2018 Immunicum AB (publ) Announces Upcoming Presentations and Attendances at Conferences in May and June Immunicum AB (publ; IMMU.ST) today announced that Company leadership will present the [...]

Sernova Announces University of Chicago Institutional Review Board (IRB) Approval of the FDA-cleared Therapeutic Cell Pouch Clinical Study

14/05/2018 - 12:00

IRB Approval Signals ‘Green Light’ for Sernova’s Clinical Protocol to Proceed LONDON, Ontario, May 14, 2018 (GLOBE NEWSWIRE) -- Sernova Corp. (TSX-V: SVA ) (OTCQB:SEOVF) (FSE:PSH), announces today it has received [...]

OraSure Technologies to Present at the UBS Global Healthcare Conference

14/05/2018 - 12:00

BETHLEHEM, Pa., May 14, 2018 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ: OSUR ), a leader in point of care diagnostic tests and specimen collection devices, today announced that Stephen S. Tang, President [...]

Healthwise Recognized for Plain-Language Excellence With 2018 Grand ClearMark Award

14/05/2018 - 12:00

BOISE, Idaho, May 14, 2018 (GLOBE NEWSWIRE) -- When people get health information they understand, they can make better health decisions. For over 40 years Healthwise has written clear and simple health education that [...]

Fennec Provides Business Update and Announces First Quarter 2018 Financial Results

14/05/2018 - 12:00

PEDMARK TM granted Breakthrough Therapy and Fast Track Designations by FDA Actively preparing for NDA submission later this year Strong financial position with $26.7 million in cash and no debt RESEARCH TRIANGLE PARK, N [...]

Amphastar Pharmaceuticals Receives FDA Approval for Calcium Chloride Injection

14/05/2018 - 12:00

RANCHO CUCAMONGA, Calif., May 14, 2018 (GLOBE NEWSWIRE) -- Amphastar Pharmaceuticals, Inc. (NASDAQ: AMPH ) announced that the U.S. Food and Drug Administration (“FDA”) granted approval of the company’s abbreviated new [...]

International Endeavors Corporation, a Medical Marijuana IP Holdings Company, Secures a $500,000 Investment Commitment From Voltage River

14/05/2018 - 12:00

TEMECULA, Calif., May 14, 2018 (GLOBE NEWSWIRE) -- via OTC PR WIRE--International Endeavors Corporation, a Medical Marijuana IP Holdings Company, today announces that the Company has received an investment commitment of [...]

Invitation: Terveystalo result audiocast and conference call on 16 May 2018

14/05/2018 - 10:21

Terveystalo Plc will publish its Interim report for January-March 2018 on 16 May 2018 at approximately 9:00 a.m. EEST (Finnish time). The company will hold an audiocast and conference call in English at 12:30 EEST ( [...]

Xbrane Biopharma and Episurf invites to a company presentation in Stockholm May 29

14/05/2018 - 09:49

Press release 2018-05-14 Xbrane Biopharma and Episurf Medical invites to a company presentation held at Episurf Medical's office at Karlavägen 60 in Stockholm on May 29, 18.00-20.30 CEST. Xbrane Biopharma will be [...]

Sanofi and Ablynx Announce the Successful Results of the Initial Tender Offer Period for Ablynx and Commencement of Squeeze-Out Tender Period

14/05/2018 - 08:10

Press Release Source: Sanofi (EURONEXT: SAN) (NYSE: SNY) Sanofi and Ablynx Announce the Successful Results of the Initial Tender Offer Period for Ablynx and Commencement of Squeeze-Out Tender Period Paris, France and [...]

mise à jour: Sanofi et Ablynx annoncent le succès des offres publiques d'acquisition sur Ablynx et le lancement d'offres de reprise

14/05/2018 - 08:10

Il sagit dune mise à jour du communiqué 08:00 14.05.2018 CEST. Explication de la mise à jour; mauvais logo. Communiqué de presse Source : Sanofi (EURONEXT: SAN) (NYSE: SNY) Sanofi et Ablynx annoncent le succès des [...]